Merck & Co Inc
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
Exterior view of the entrance to Merck headquarters on February 05, 2024 in Rahway, New Jersey. Spencer Platt | Getty Images Merck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as it posted strong sales of its blockbuster cancer drug Keytruda and vaccine products. The pharmaceutical giant also raised and narrowed its […]
Read MoreBiotech stocks are ready to break out. They just need one more thing
While debate rages on about when the Federal Reserve might start cutting interest rates, biotech industry analysts are making the case that the argument for stocks in the sector is growing. The central bank has held rates steady since last July as it patiently waits for more signs that inflation is cooling. But a reading […]
Read MoreShares producing the biggest moves midday: GameStop, Merck, Carnival, Cintas and far more
Verify out the firms creating headlines in midday trading. GameStop — GameStop shed 15% following the video recreation retailer claimed decreased fourth-quarter income from a yr ago. The corporation also stated it axed an unspecified amount of roles to trim expenditures. Merck — Merck jumped 5% immediately after the U.S. Foodstuff and Drug Administration on […]
Read MoreStocks earning the greatest moves premarket: Robinhood, GameStop, Merck and additional
Look at out the firms building headlines in premarket investing. Robinhood — Shares of the brokerage business jumped additional than 6% immediately after unveiling its Robinhood Gold Card, a credit rating card wherever funds again can be deposited into a brokerage account. Concentrix — Shares slipped approximately 4% on the back of disappointing fiscal second-quarter […]
Read MoreFda approves Merck's drug for exceptional, deadly lung ailment
The Foods and Drug Administration on Tuesday accredited a drug from Merck created to handle a progressive and existence-threatening lung situation in a earn for each the drugmaker and for patients suffering from the uncommon illness. The company greenlighted the therapy, which will be marketed as Winrevair, for older people with pulmonary arterial hypertension. The […]
Read MoreHealthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
3D Illustration of a human liver organ. magicmine | iStock | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Millions of Americans with a common and potentially life-threatening form of liver disease will soon have access to the first-ever treatment for […]
Read MoreHealthy Returns: What’s next in the legal fight over Medicare drug price negotiations
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! The bitter legal battle […]
Read MorePfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know
Nurphoto | Nurphoto | Getty Images Pfizer is ready to move on from Covid. Now, the company is betting on cancer drugs to help it regain its footing after a rocky year marked by the rapid decline of its Covid business. It just might take a while before that bet pays off. Pfizer pitched its […]
Read MoreViking stock doubled Tuesday. In this article's the place the following moves in the weight problems room could arrive from
Anti-weight problems drugmakers Novo Nordisk and Eli Lilly have a big lead on their competitiveness, but supplied the large and beneficial marketplace, rivals are nevertheless keen to sign up for the race. Bank of America analyst Geoff Meacham has been quite bullish about the option, which he phone calls “unparalleled” offered the prevalence of obesity […]
Read More